Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country
Phase
Study type
777 / 777 trials
PostedSponsorStudyPhaseStatus
18 Nov 2026Ambu A/SDenmarkAI-Guided Bronchoscopy Using the Broncho AI NavigatorNot applicableRecruiting18 Nov 2026AstraZenecaIndiaA Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With HyperkalaemiaPhase 4Recruiting18 Nov 2026Beijing Baheal Wisart Medical Research Co., LtdChinaSafety, Tolerability, and Pharmacokinetic Study of Single and Multiple Ascending Dose of YY524051 Tablets in Healthy Adults.Phase 1Not Yet Recruiting18 Nov 2026Beijing Xunsheng Biomedical Research Co., Ltd.ChinaSafety, Tolerability, and Efficacy of a Therapeutic Intervention for HPV16/18 InfectionNot applicableRecruiting18 Nov 2026Braveheart Bio, Inc.BHB-1893 vs. Placebo for Symptomatic Non-obstructive Hypertrophic CardiomyopathyPhase 3Not Yet Recruiting18 Nov 2026BrocShot IncUnited StatesA Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected SkinNot applicableNot Yet Recruiting18 Nov 2026CASI pharmaceuticals, Inc.ChinaA Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune ThrombocytopeniaPhase 2Not Yet Recruiting18 Nov 2026CellinCellsSouth KoreaDevelopment of an ASRS-Based Photoguide for a Clinical Trial of TRTP-101 in Adults With Atrophic ScarsNot Yet Recruiting18 Nov 2026Chengdu Zenitar Biomedical Technology Co., LtdAustraliaA Phase I Clinical Study of Oral ZL-65 Tablets in Healthy and Obese Participants With Cardiovascular RiskPhase 1Not Yet Recruiting18 Nov 2026Coherus Oncology, Inc.United StatesA Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid TumorsPhase 1, Phase 2Recruiting18 Nov 2026Cugene Inc.United StatesA Phase I Dose-Escalation Study of CUG279 in Participants With Select Advanced or Metastatic Solid TumorsPhase 1Recruiting18 Nov 2026Diabetes Free, Inc.GermanyDual-targeting of B & T Cell Pathways Evaluation TrialPhase 1, Phase 2Recruiting18 Nov 2026Driscoll'sUnited StatesA Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy AdultsNot applicableNot Yet Recruiting18 Nov 2026Eli Lilly and CompanyChinaA Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3839056 in Healthy ParticipantsPhase 1Not Yet Recruiting18 Nov 2026EpetomeUnited StatesA Clinical Trial to Evaluate the Effects of the Synbiotic Dual Cap® on Gastrointestinal Comfort in Adults Initiating GLP-1 or Dual-Incretin Therapy for Weight Loss.Not applicableNot Yet Recruiting18 Nov 2026Etta VitaUnited StatesA Clinical Trial to Evaluate the Effects of a Supplement on Appetite, Gut Health, and Blood SugarNot applicableCompleted18 Nov 2026Frontier Medicines CorporationPh 1/2 Study to Evaluate Safety & Tolerability of FMC-242 Alone and in Combination in Adults With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting18 Nov 2026Fujian Akeylink Biotechnology Co., Ltd.ChinaA Study on the Pharmacokinetics and Safety of GST-HG141 Tablets in Participants With Hepatic Impairment and Normal Liver FunctionPhase 1Recruiting18 Nov 2026Gaia AGGermanyInvestigating the Effectiveness of Calisda, a Digital Health Intervention for Patients With Menopause SymptomsNot applicableNot Yet Recruiting18 Nov 2026Gan & Lee Pharmaceuticals.ChinaA Pharmacokinetics Study of GZR33 Injection at Different Injection SitesPhase 1Not Yet Recruiting18 Nov 2026Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsUnited StatesAleniglipron Renal Impairment StudyPhase 1Not Yet Recruiting18 Nov 2026GlaxoSmithKlineA Study of GSK5864399 Administered Alone or in Combination With Other Anti-cancer Agents in Participants With Solid TumoursPhase 1, Phase 2Not Yet Recruiting18 Nov 2026GlaxoSmithKlineA Study of Risvutatug Rezetecan in Combination With Atezolizumab in Participants With Extensive Stage Small Cell Lung Cancer (EMBOLD-SCLC-303)Phase 3Not Yet Recruiting18 Nov 2026Good Kitty CoUnited StatesA Clinical Trial to Evaluate the Effects of a Supplement on Urinary SymptomsNot applicableActive Not Recruiting18 Nov 2026Immorna Biotherapeutics, Inc.Phase 1 Trial to Assess Safety and Immunogenicity of Self-replicating RNA (srRNA) Herpes Zoster Vaccine (JCXH-105)Phase 1Not Yet Recruiting18 Nov 2026Immuneering CorporationPhase 2 Study to Evaluate Dose Optimization and Anti-tumor Activity of Atebimetinib in Participants With Advanced or Metastatic NSCLC.Phase 2Not Yet Recruiting18 Nov 2026Interlude Biopharma Co.Clinical Trial to Evaluate the Protective Effect of Larazotide Acetate in Individuals With Well-Controlled Celiac DiseasePhase 3Not Yet Recruiting18 Nov 2026IpsenA Phase I/II Study to Learn About the Safety and Effects of a New Medicine Called IPN60350 Alone or in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Solid TumorsPhase 1, Phase 2Not Yet Recruiting18 Nov 2026Longbio PharmaChinaA Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite Treatment With H1 AntihistaminesPhase 3Not Yet Recruiting18 Nov 2026MultiValent Biotherapies, Inc.United StatesA Phase 1 Study of MVB-101 Administered Intraprostatically in Patients With Localized Prostate Cancer Who Are Scheduled for Radical ProstatectomyPhase 1Recruiting18 Nov 2026My Myracle Sdn.BhdMalaysiaEffects of PosBion® Supplementation on Intestinal Barrier Function in Adults With Irritable Bowel SyndromeNot applicableNot Yet Recruiting18 Nov 2026N-Power MedicineA Prospective External Control Arm Study in Colorectal CancerNot Yet Recruiting18 Nov 2026Novartis PharmaceuticalsA Study Characterizing the Elevated Liver Enzymes in Ribociclib Treated HR+ HER2- Advanced Breast Cancer Patients Using a Machine Learning Approach With Real-world DataNot Yet Recruiting18 Nov 2026Novo Nordisk A/SUnited StatesExamination of How the Duration of Fasting and Temporary Stopping of Zenagamtide Dosing Affect the Amount of Food Left in the Stomach in Adults With Overweight or Obesity, With or Without Type 2 DiabetesPhase 1Not Yet Recruiting18 Nov 2026SanofiFirst-in-human Study of SAR448632 in Healthy Adult ParticipantsPhase 1Not Yet Recruiting18 Nov 2026Shanghai Henlius BiotechAustralia, ChinaA Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX49 in Advanced/Metastatic Solid TumorsPhase 1Not Yet Recruiting18 Nov 2026Sleep Cycle ABAustraliaDevelopment of the Sleep Cycle App's Tracking Abilities of Sleep and Sleep BehaviorsCompleted18 Nov 2026South Rampart Pharma, Inc.United StatesA Study Evaluating the Efficacy and Safety of Novel Non-Opioid SRP-001 in Acute Pain After Molar ExtractionPhase 2Not Yet Recruiting18 Nov 2026The Collagen Co. - GLP-1 UsersUnited StatesA Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Nutritional Adequacy, Body Composition, Skin Health, Satiety, and Overall Wellness in Adults Using GLP-1 or Dual-Incretin Medications for Weight ManagementNot applicableNot Yet Recruiting18 Nov 2026The Collagen Co. - GLP-1 UsersUnited StatesA Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health OutcomesNot applicableNot Yet Recruiting18 Nov 2026Trevi TherapeuticsUnited StatesA Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy ParticipantsPhase 1Recruiting18 Nov 2026Xiamen Amoytop Biotech Co., Ltd.ChinaPhase Ib Clinical Trial of ACT201 Injection in Participants With Treatment-Naïve Chronic Hepatitis BPhase 1Not Yet Recruiting18 Nov 2026Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.ChinaDiagnostic Performance and Safety of Ragweed Pollen and Dog Dander Skin Prick Test SolutionsPhase 3Not Yet Recruiting17 Nov 2026Abiomed Inc.United StatesLeft Ventricular Impella Device Real-World Evaluation in Pediatric PatientsActive Not Recruiting17 Nov 2026Actithera INC.177Lu-ACT319 in FAP Expressing Solid TumorsPhase 1, Phase 2Not Yet Recruiting17 Nov 2026Aerin MedicalUnited StatesEvaluating Posterior Nasal Nerve Neurolysis for Migraine ReliefNot applicableCompleted17 Nov 2026Aerys BiosciencesAustraliaFirst-in-Human Study of ABS-169 in Healthy VolunteersPhase 1Not Yet Recruiting17 Nov 2026Aligos TherapeuticsUnited StatesSafety, Tolerability, and Pharmacokinetics of Supratherapeutic Doses of ALG-000184 (Parts A and B) and the Absorption, Metabolism, Excretion, and Absolute Bioavailability of ALG-001075 Following a Single Oral Dose of [14C]ALG-000184 and a Single Intravenous Dose of [13C7,15N1]ALG-001075 (Part C)Phase 1Not Yet Recruiting17 Nov 2026Ashvattha Therapeutics, Inc.United StatesStudy Evaluating Safety & Tolerability of Migaldendranib in US Healthy VolunteersPhase 1Active Not Recruiting17 Nov 2026AstraZenecaUnited States, Argentina, AustraliaA Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCPhase 2Not Yet Recruiting

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.